Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

BackgroundCheckpoint inhibitor-related pneumonitis (CIP) is a potentially fatal immune-related adverse event that occurs during treatment with immune checkpoint inhibitors (ICIs). However, the roles played by peripheral blood parameters in CIP development remain unclear. Here, we aimed to identify w...

Full description

Bibliographic Details
Main Authors: Xinqing Lin, Haiyi Deng, Yilin Yang, Jianhui Wu, Guihuan Qiu, Suyang Li, Xiaohong Xie, Ming Liu, Zhanhong Xie, Yinyin Qin, Yong Song, Chengzhi Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
checkpoint inhibitor-related pneumonitis
immune checkpoint inhibitor
interleukin-6
lymphocyte
albumin
lung cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.698832/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.698832/full

Similar Items